# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Artelon is a privately held company specializing in innovative soft tissue fixation products for foot and ankle and sports medi...
Goldman Sachs analyst David Roman initiates coverage on Stryker (NYSE:SYK) with a Neutral rating and announces Price Target ...
Needham analyst upgrades SYK to Buy, expects new products & M&A to drive upside in revenue & EPS. Strong backlog &a...
Needham analyst Mike Matson upgrades Stryker (NYSE:SYK) from Hold to Buy and announces $392 price target.